Search Results - joseph+pisegna

2 Results Sort By:
SYNERGISM BETWEEN PROTON PUMP INHIBITORS AND A GI PEPTIDE IN REDUCING ACID SECRETION
Case 2000-093UCLA researchers in the Department of Medicine have discovered a novel method to improve the efficacy of proton pump inhibition. BACKGROUND:A vast number of pathological conditions are characterized by over-secretion of gastric acid, such as Zollinger/Ellison syndrome (ZES), gastroesophageal reflux disease (GERD), peptic ulcer disease,...
Published: 7/19/2023   |   Inventor(s): Joseph Pisegna
Keywords(s): Gastroenterology & Digestive Disease, Renal, Therapeutics & Vaccines
Category(s): Therapeutics > Gastroenterology, Therapeutics > Renal
2018-199 Identification of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, and Hepatic Fibrosis
Identification Of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, Hepatic FibrosisSUMMARYUCLA researchers in the Departments of Medicine and Human Genetics have identified a sequence of long, non-coding RNA that plays a role in the regulation of intracellular lipogenesis and holds potential for diagnosing and treating metabolic diseases,...
Published: 7/19/2023   |   Inventor(s): Jihane Benhammou, Paivi Pajukanta, Joseph Pisegna
Keywords(s): Diagnostic Markers & Platforms, Metabolic Diseases, Therapeutics & Vaccines
Category(s): Diagnostic Markers, Therapeutics, Therapeutics > Metabolism And Endocrinology